Core Viewpoint - Hangzhou Anjisi Medical Technology Co., Ltd. has established a detailed share repurchase system to promote standardized operations, complying with relevant laws and regulations [1] Group 1: Repurchase Conditions and Principles - The company’s share repurchase is primarily applicable for reducing registered capital, employee stock ownership or equity incentives, convertible bond conversions, and maintaining company value and shareholder rights [2] - Specific conditions for repurchase to maintain company value include: stock closing price below the latest net asset per share, cumulative decline of 20% over 20 consecutive trading days, and below 50% of the highest closing price in the past year [2] - The repurchase must comply with relevant regulations, not harm the rights of shareholders and creditors, and must follow decision-making procedures and information disclosure obligations [2] Group 2: Implementation Procedures and Disclosure - Proposals for share repurchase can be made by eligible proposers to the board, which must promptly review and announce related content [3] - The repurchase plan must include detailed information such as purpose, method, price range, and funding sources, and must be disclosed within a specified timeframe [3] - Changes or termination of the repurchase plan require proper justification and must be submitted for review [3] Group 3: Handling of Repurchased Shares - Repurchased shares must be handled according to disclosed purposes, either transferred or canceled, with specific conditions for sale after a designated period [4] - Sale of repurchased shares must adhere to relevant requirements, including price declaration, sale timing, and quantity restrictions, with timely disclosure of sale progress and results [4] Group 4: Daily Supervision - The company and related parties must manage insider information and report relevant insider information when disclosing the repurchase plan [4] - The newly established share repurchase system provides clear operational guidelines for potential future repurchase actions, helping to protect the legal rights of the company and its shareholders, and promoting healthy and stable development [4]
杭州安杰思医学科技股份有限公司:规范股份回购制度,明确操作细则与监管要求